Evotec SE 9M 2022 Interim Statement

Evotec SE's interim financial statement for the first nine months of 2022, presented November 9, 2022. The document includes regulatory disclaimers and forward-looking statements regarding the company's business operations, financial performance, and strategic objectives for its pharmaceutical development and manufacturing operations.